Review
doi: 10.1016/s0304-3835(03)00086-7.
Genes co-amplified with MYCN in neuroblastoma: silent passengers or co-determinants of phenotype?
Affiliations
- PMID: 12880964
- DOI: 10.1016/s0304-3835(03)00086-7
Item in Clipboard
Review
Genes co-amplified with MYCN in neuroblastoma: silent passengers or co-determinants of phenotype?
Cancer Lett.
.
Abstract
Amplification of the MYCN oncogene in neuroblastoma is associated with poor prognosis. The amplified unit of DNA can be up to 1 Mb in size and so could contain additional genes that affect tumour phenotype. Identification of such genes may assist in optimising the determination of prognosis, and could provide new targets for treatment. Three genes have so far been identified, which are frequently co-amplified with MYCN in neuroblastoma, DDX1, NAG and N-cym. In this review, the known or putative properties of the protein products of the genes are discussed, and their possible roles in determining tumour behaviour are assessed.
Similar articles
-
Relationship of DDX1 and NAG gene amplification/overexpression to the prognosis of patients with MYCN-amplified neuroblastoma.J Cancer Res Clin Oncol. 2007 Mar;133(3):185-92. doi: 10.1007/s00432-006-0156-y. Epub 2006 Oct 7. J Cancer Res Clin Oncol. 2007. PMID: 17028906 Free PMC article.
-
Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma.Genes Chromosomes Cancer. 1995 Nov;14(3):196-203. doi: 10.1002/gcc.2870140307. Genes Chromosomes Cancer. 1995. PMID: 8589036
-
Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma.Oncogene. 1995 Apr 6;10(7):1417-22. Oncogene. 1995. PMID: 7731693
-
Amplification of the MYCN oncogene and deletion of putative tumour suppressor gene in human neuroblastomas.Brain Pathol. 1990 Sep;1(1):41-6. doi: 10.1111/j.1750-3639.1990.tb00637.x. Brain Pathol. 1990. PMID: 1669692 Review.
-
The MYCN oncogene and differentiation in neuroblastoma.Semin Cancer Biol. 2011 Oct;21(4):256-66. doi: 10.1016/j.semcancer.2011.08.001. Epub 2011 Aug 9. Semin Cancer Biol. 2011. PMID: 21849159 Review.
Cited by
-
MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment.Cancers (Basel). 2022 Sep 12;14(18):4421. doi: 10.3390/cancers14184421. Cancers (Basel). 2022. PMID: 36139583 Free PMC article. Review.
-
Array comparative genomic hybridization in retinoma and retinoblastoma tissues.Cancer Sci. 2009 Mar;100(3):465-71. doi: 10.1111/j.1349-7006.2008.01070.x. Epub 2009 Jan 29. Cancer Sci. 2009. PMID: 19183342 Free PMC article.
-
Chromosome 1p36 candidate gene ZNF436 predicts the prognosis of neuroblastoma: a bioinformatic analysis.Ital J Pediatr. 2023 Oct 31;49(1):145. doi: 10.1186/s13052-023-01549-x. Ital J Pediatr. 2023. PMID: 37904225 Free PMC article.
-
Gene amplification as double minutes or homogeneously staining regions in solid tumors: origin and structure.Genome Res. 2010 Sep;20(9):1198-206. doi: 10.1101/gr.106252.110. Epub 2010 Jul 14. Genome Res. 2010. PMID: 20631050 Free PMC article.
-
Silencing of Nicotiana benthamiana Neuroblastoma-Amplified Gene causes ER stress and cell death.BMC Plant Biol. 2013 Apr 27;13:69. doi: 10.1186/1471-2229-13-69. BMC Plant Biol. 2013. PMID: 23621803 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
